Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling

Bibliographic Details
Main Authors:	Carlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, Paola Lanuti, Scott I. Abrams, Zhinan Yin, Li‐Fan Lu, Emma Di Carlo
Format:	Article
Language:	English
Published:	Wiley 2021-02-01
Series:	Clinical and Translational Medicine
Subjects:	IFNγ interleukin‐30 triple negative breast cancer tumor microenvironment
Online Access:	https://doi.org/10.1002/ctm2.278

Internet

https://doi.org/10.1002/ctm2.278